Principal Street Partners, LLC Abb Vie Inc. Transaction History

Principal Street Partners, LLC

$615 Million
Q3 2024

A detailed history of Principal Street Partners, LLC transactions in Abb Vie Inc. stock. As of the latest transaction made, Principal Street Partners, LLC holds 36,421 shares of ABBV stock, worth $6.6 Million. This represents 1.17% of its overall portfolio holdings.

Number of Shares

36,421

Previous 47,257 22.93%

Holding current value

$6.6 Million

Previous $8.11 Million 11.26%

% of portfolio

1.17%

Previous 1.46%

23 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Nov 13, 2024	SELL	$163.84 - $199.33 $1.78 Million - $2.16 Million	-10,836 Reduced 22.93%	36,421 $7.19 Million
Q2 2024 Aug 14, 2024	SELL	$154.79 - $180.76 $13,002 - $15,183	-84 Reduced 0.18%	47,257 $8.11 Million
Q1 2024 May 15, 2024	BUY	$159.82 - $182.1 $1.44 Million - $1.65 Million	9,037 Added 23.59%	47,341 $8.62 Million
Q4 2023 Feb 07, 2024	SELL	$137.6 - $154.97 $329,827 - $371,463	-2,397 Reduced 5.89%	38,304 $5.94 Million
Q3 2023 Nov 01, 2023	BUY	$133.59 - $154.65 $396,361 - $458,846	2,967 Added 7.86%	40,701 $6.07 Million
Q2 2023 Aug 21, 2023	SELL	$132.51 - $164.9 $198,367 - $246,855	-1,497 Reduced 3.82%	37,734 $5.08 Million
Q1 2023 May 11, 2023	BUY	$144.61 - $166.54 $195,657 - $225,328	1,353 Added 3.57%	39,231 $6.25 Million
Q4 2022 Feb 15, 2023	BUY	$138.31 - $165.87 $33,609 - $40,306	243 Added 0.65%	37,878 $6.13 Million
Q3 2022 Nov 14, 2022	SELL	$134.21 - $153.93 $15,568 - $17,855	-116 Reduced 0.31%	37,635 $5.05 Million
Q2 2022 Aug 15, 2022	SELL	$137.62 - $174.96 $1.44 Million - $1.83 Million	-10,446 Reduced 21.67%	37,751 $5.78 Million
Q1 2022 May 05, 2022	SELL	$131.98 - $163.75 $9,238 - $11,462	-70 Reduced 0.15%	48,197 $7.81 Million
Q4 2021 Feb 07, 2022	BUY	$107.43 - $135.93 $239,891 - $303,531	2,233 Added 4.85%	48,267 $6.54 Million
Q3 2021 Nov 10, 2021	SELL	$106.4 - $120.78 $73,096 - $82,975	-687 Reduced 1.47%	46,034 $4.97 Million
Q2 2021 Aug 10, 2021	SELL	$105.21 - $117.21 $7.01 Million - $7.81 Million	-66,610 Reduced 58.77%	46,721 $5.26 Million
Q1 2021 May 13, 2021	BUY	$102.3 - $112.62 $7.09 Million - $7.81 Million	69,351 Added 157.69%	113,331 $12.3 Million
Q4 2020 Feb 16, 2021	SELL	$80.49 - $108.67 $295,720 - $399,253	-3,674 Reduced 7.71%	43,980 $4.71 Million
Q3 2020 Nov 12, 2020	SELL	$85.91 - $100.83 $569,841 - $668,805	-6,633 Reduced 12.22%	47,654 $4.17 Million
Q2 2020 Aug 14, 2020	SELL	$73.37 - $98.18 $5.82 Million - $7.79 Million	-79,333 Closed	0 $0
Q1 2020 May 14, 2020	SELL	$64.5 - $97.79 $1.21 Million - $1.84 Million	-18,831 Reduced 19.18%	79,333 $6.05 Million
Q4 2019 Mar 04, 2020	BUY	$72.13 - $90.25 $239,687 - $299,900	3,323 Added 3.5%	98,164 $8.69 Million
Q3 2019 Nov 14, 2019	BUY	$62.98 - $75.72 $4.44 Million - $5.33 Million	70,440 Added 288.68%	94,841 $7.18 Million
Q2 2019 Aug 15, 2019	SELL	$65.7 - $83.98 $2.05 Million - $2.63 Million	-31,270 Reduced 56.17%	24,401 $1.77 Million
Q1 2019 May 15, 2019	BUY	$77.14 - $90.79 $4.29 Million - $5.05 Million	55,671 New	55,671 $4.49 Million

Others Institutions Holding ABBV

# of Institutions

3,854

Shares Held

1.25B

Call Options Held

16.8M

Put Options Held

12.2M

View Full List

About AbbVie Inc.

Ticker ABBV
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 1,768,099,968
Market Cap $320B
Description
AbbVie Inc. discovers, develops, manufactures, and sells pharmaceuticals in the worldwide. The company offers HUMIRA, a therapy administered as an injection for autoimmune and intestinal Behçet's diseases; SKYRIZI to treat moderate to severe plaque psoriasis in adults; RINVOQ, a JAK inhibitor for the treatment of moderate to severe active rheuma...

More about ABBV

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Principal Street Partners, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Principal Street Partners, LLC with notifications on news.

Account

Principal Street Partners, LLC Abb Vie Inc. Transaction History